About 1 result found for searched term "Y08284" (0.14 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25523 | Y08284 | Epigenetic Reader Domain |
| Y08284 is a potent, selective, oral active CBP bromodomain inhibitor with an IC50 of 4.21 nM. Y08284 suppresses the proliferation of prostate cancer cell lines LNCaP, C4-2B, and 22Rv1. Y08284 has antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
